ArticleFoods (Basel, Switzerland)2025
Evaluation of Commercial Carob Syrups (
Article in Foods (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Effects of Specific Carob (Nutrients · 2026Trial
- Carob (Nutrients · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundMetabolic disorders such as diabetes and dyslipidaemia are intricately connected to dietary habits. This has resulted in an increasing interest in functional foods that may offer benefits for glycaemic and lipid regulation. This study aims to evaluate the effects of two commercial carob syrups on postprandial glycaemic response, serum lipid profile, and anthropometric measurements in healthy adults.
methodsThe research comprised two complementary randomized and controlled trials: (i) a glycaemic test involving 20 volunteers and (ii) a six-week intervention that assessed serum cholesterol levels and body composition in a cohort of 72 participants. Volunteers were between the ages of 18 and 65 years in both studies.
resultsBoth syrups displayed statistical significance in low glycaemic indices (GI = 56.04 ± 13.75, and 60.46 ± 26.92%) and an attenuation of the postprandial glucose response by 16% compared to glucose control (
conclusionsThese findings indicate that carob syrups may serve as promising functional ingredients with a reduced glycaemic impact and potential cardiometabolic benefits. However, they should be interpreted as preliminary evidence. The novelty of the present study lies mainly in the use of commercially available syrups in a healthy cohort, where effects on lipids and anthropometry were modest but consistent.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.